NewLimit Alternatives & Competitors
12 companies similar to NewLimit — NewLimit is a biotechnology company working to extend human healthspan by develo...
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Sunnyvale, United States
Ochre Bio
Oxford, United Kingdom
Transgene
Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IO™ and...
Illkirch-graffenstaden, F...
Basilard BioTech, Inc.
Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies
United States
Track all NewLimit competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innova...
Cambridge, United Kingdom
TenSixty Biosciences
We're on a mission to create transformative drugs that will save lives and redefine oncolo...
APTBIO
Cutting-Edge Omics for Your Research.
Hong Kong S.a.r.
Ciloa SAS
Inspired by Exosomes
Montpellier, France
Avilar Therapeutics
Pioneering the discovery and development of extracellular protein degraders.
Waltham, United States
Baseimmune
Pioneering the next generation of active immunotherapies for chronic diseases
London, United Kingdom
Takara Bio USA, Inc.
Empowering gene and cell therapy with comprehensive manufacturing and customer services.
San Jose, United States
KAICO Ltd.
Changing the World with Silkworms
Fukuoka, Japan
About NewLimit
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.
Development of anti-aging medicines, Epigenetic reprogramming research, Genomic testing and analysis, AI-driven therapeutic design
Biotechnology companies, Healthcare providers, Research institutions, Aging population
Healthspan Extension, Epigenetic Reprogramming, Age-related Diseases, Regenerative Medicine, Functional Genomics, Therapeutic Development, Pooled Perturbation Screening, Machine Learning In Biotech, Epigenetics, Disease Biology, Genomic Research, Unmet Medical Needs, Cellular Regeneration
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches NewLimit and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at NewLimit on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.